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It is a stipulation of the professional bodies that Non-Medical Prescribers are 
accountable and responsible for their own decisions in respect of safe, patient-centred 
care, including prescribing (Nursing & Midwifery Council, 2018; Health & Care 
Professions Council, 2016; General Pharmaceutical Council, 2017). A collaboration in 
2019 between the Medical Royal Colleges, healthcare regulators and other 
professional organisations identified ten high level principles that are fundamental to 
safe, good quality remote consultations and prescribing. Within the current climate of 
an NHS that is adapting to the Covid-19 pandemic, this collaborative guidance could 
not have been more timely. The Royal Colleges et al (2019) identify that remote 
consultations and prescribing can provide benefit to patients, save finite resources and 
promote convenient access to healthcare services. However, they stipulate that 
safeguards must be in place before the prescriber considers this mechanism of 
providing medication to our patients.      
Broadhead (2020) describes remote prescribing as that which occurs in the context of 
the prescriber and the patient being physically or geographically remote from each 
other. Its success is dependent on robust consultation techniques including gaining 
valid consent, building effective dialogue, fostering rapport, accurate history taking and 
observation of the patient when required. In order to maintain safety, within the  Royal 
Pharmaceutical Society (2016) A competency framework for all prescribers, the 
Prescribing Governance domain, competence 7.1, advises that the prescriber 
“identifies the potential risks associated with prescribing via remote media (telephone, 
email or through a third party) and takes steps to minimise them”. Williams, (2019) 
suggests that whilst being physically absent from the patient is not ideal in every 
circumstance, remote prescribing has ultimately improved patient care for some. He 
does advocate, however, that to ensure patient safety is not compromised, the 
development of protocols and the undertaking of robust risk assessment are essential 
components of remote prescribing. Williams (2019) further states that working 
remotely still allows the prescriber to issue electronic prescriptions, order and interpret 
investigations, manage long-term conditions and undertake medication reviews by 
telephone. This said, Raymond (2019) suggests that it is paramount that remote 
prescribing is undertaken with caution and in accordance with the guidance from the 
Medical Defence Union (MDU) (2018).  The MDU urges prescribers to consider the 
following: you are satisfied that you are in a position to prescribe safely; are prepared 
to ask the patient to come in for a physical examination; have adequate knowledge of 
the patient’s health and that you are satisfied the medication you prescribe serves the 
patient’s needs. 
Reflect on your own prescribing role and consider the scenarios and calculations 
below: 
Question 1 
James is 65 years old and currently shielding. You have managed this patient for many 
years in Primary Care and know his condition and treatment regime well. You 
undertake a telephone consultation at James’ request and subsequently diagnose an 
infective exacerbation of COPD. You prescribe antibiotics and oral steroids as follows: 
Amoxicillin 500mg capsules – one capsule three times a day (8 hourly) for 7 days 
Prednisolone 5mg tablets – 6 tablets daily in the morning for 7 days 
a. What is the daily dose of amoxicillin in g?  
b. How many capsules of amoxicillin should be supplied in total  
c. What is the total daily dose of prednisolone in mg?  
d. How many tablets of prednisolone need to be supplied for 7 days?  
Question 2 
Marc is 34 and attended A&E two days ago following a fall from his mountain bike. An 
X-Ray showed no bony injury and a soft tissue injury was diagnosed. He was advised 
to take paracetamol 500mg tablets x 2 every 4-6 hours for pain relief (maximum 8 
tablets in 24 hours). During your remote consultation today, he explained that, despite 
taking the maximum dose of paracetamol, his pain was still moderate to severe. You 
take a comprehensive history and decide that adding an NSAID would be beneficial. 
As there are no contraindications to this medication, you prescribe Ibuprofen 200mg 
tablets at 1-2 tablets every 6 hours for the next 7 days, but advise him to purchase 
these over the counter. 
a. If Marc is taking the maximum dose of 8 x paracetamol tablets every 24 hours, 
how many tablets will he consume over 2 weeks?  
b. Marc has an unopened box of paracetamol 500mg tablets at home. It contains 
30 tablets. If he takes paracetamol as prescribed for the next 10 days, how 
many more boxes of 30 tablets will he need to purchase?  
c. How many paracetamol will Marc have left after 10 days treatment?  
d. Assuming Marc takes the maximum prescribed dose of ibuprofen (200mg x 2 
tablets every 6 hours), how many tablets will Marc need for 7 days treatment?  
Question 3 
Jeff, aged 46 has Hashimoto’s thyroiditis. He has been taking thyroxine 
150micrograms daily for the last 12 months. You have the results of his last thyroid 
function tests (TFT) which show an elevated thyroid-stimulating hormone (TSH) and 
a low T4. You undertake a telephone consultation with Jeff to discuss an increase in 
treatment. It is agreed that Jeff should now take 200 micrograms thyroxine daily. You 
prescribe Levothyroxine sodium 100microgram tablets, two daily in the morning. 
a. Jeff currently has 60 x 50 microgram tablets and 60 x 100 microgram tablets in 
stock. How many days’ supply of thyroxine does Jeff have if he uses all of these 
before requiring a new prescription?  
b. How many 100microgram tablets will Jeff require for 28 days’ treatment on his 
new dose?   
You arrange to check Jeff’s TFTs in 6 months. Levothyroxine 100microgram tablets 
cost £1.50 for 28 tablets. 
c. Assuming one calendar month is 28 days, what is the total cost of this 
medication for a six-month period?  
d. If Jeff’s dose is then subsequently increased by 25%, what would the new daily 
dose of thyroxine be?  
 
 
Question 4  
Mary, aged 26 is a registered nurse and requests a telephone consultation with you 
this morning. She is complaining of recurrent urinary symptoms. Mary had undertaken 
urinalysis at work yesterday and this was positive for leucocytes and nitrites using 
Multistix®. You are satisfied that antibiotics are required for Mary, she is not pregnant 
or breastfeeding and you have a choice to prescribe immediate release or modified 
release Nitrofurantoin. In order to promote concordance, the treatment plan was 
discussed with Mary, offering either: 
Option 1: Nitrofurantoin 50mg tablets (immediate release) 1 tablet four times a day for 
7 days 
or 
Option 2: Nitrofurantoin 100mg capsules (modified release) 1 capsule twice a day for 
7 days 
a. How many immediate release tablets would need to be supplied for Mary?  
b. How many modified release capsules would need to be supplied for Mary?  
c. If immediate release tablets cost £35.00 per 28 tablets and modified release 
capsules cost £10.42 per 30 capsules, which regime is the most cost-effective?  
d. When prescribing Option 2, how much Nitrofurantoin (in g) would be taken in 
total by Mary over the 7-day period?  
Question 5  
Daniel, aged 56 received a diagnosis of Stage 1 hypertension two years ago. He was 
initially prescribed an ACE inhibitor but has not been compliant with the regime for 
approximately 6 months. Daniel has been recording his blood pressure twice daily as 
you requested and he demonstrates a correct technique to you today during the Skype 
consultation.   The readings indicate that treatment is required. He has no renal 
impairment or other contraindication to recommencing an ACE inhibitor. You decide 
to commence Ramipril 2.5mg tablets once daily and review him in 2 weeks. 
a. How many Ramipril 2.5mg tablets will you prescribe for 2 weeks?  
b. How many mg of Ramipril will Daniel have taken over 1 week?  
After 2 weeks, Daniel’s blood pressure remains uncontrolled. You increase the 
strength of Ramipril by 100%. 
c. What is the strength of Ramipril you now prescribe? 
d. How many mg of Ramipril will Daniel consume until his next review in 28 days?  
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b. 21 capsules 
c. 30mg 
d. 42 tablets 
 
Q2 
a. 112 tablets 
b. 2 boxes 
c. 10 tablets 
d. 56 tablets 
 
Q3 
a. 45 days (use 2 x 100 microgram tablets for 30 days then 4 x 50 microgram tablets for 15 days) 





a. 28 tablets 
b. 14 capsules 




a. 14 tablets 
b. 17.5mg 
c. 5mg 
d. 140mg 
 
